Choksi Laboratories Limited (526546) Fair Value & Analysis
Other · IN · Market cap ₹309M
Fair value as of: Jul 4, 2026
From 14 valuation models · updated today
Share price −0.8% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹89.65 – ₹228.05 · fair‑value band ₹35.80 – ₹59.93 · the ₹121.05 price screens above the ₹47.94 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Choksi Laboratories Limited (526546) currently trades at ₹121.05, while our model-based Fair Value estimate is ₹47.94 — implying the stock looks roughly 60.4% overvalued today. We read business quality at 44/100 (below-average quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, Choksi Laboratories Limited generated revenue of ₹248M at a net margin of -19.7%. Revenue declined 41.2% year over year. Net debt stands at ₹300M. The stock trades on a trailing P/E of 150.7. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. The company's contract laboratory services include pharmaceutical, food and beverages, water, and construction material analysis. Its instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. The company also offers environment management, laboratory, waste water management, and air pollution monitoring services. In addition, it provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, auditing, laboratory set-up and management, and environment management services. Further, the company offers assaying and hallmarking services for gold and silver. It primarily serves …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Choksi Laboratories Limited reported revenue of ₹460M in FY2026 versus ₹300M in FY2022, a compound +11.2%/yr. Reported net income was ₹19.6M in FY2026, compounding +75.5%/yr from FY2022.
Is 526546 fairly valued? → Check now
Similar stocks
6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €209.16 | -60% |
| Sony Corporation SON1 | €17.58 | €39.38 | +124% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $28.75 | +71% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
Explore undervalued stocks
Frequently asked questions
Is Choksi Laboratories Limited (526546) undervalued?
What is the fair value of 526546?
What is the quality score of 526546?
What is the revenue of Choksi Laboratories Limited (526546)?
What is the net profit margin of 526546?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.